L. V. D. Berg

The Musculoskeletal System in Pompe Disease: Pathology, consequences and treatment options

L. V. D. Berg, 2014 .

Reply to the letter to the editor by Papadimas et al.: “Bone mineral density in adult patients with Pompe disease”

W. Hop, M. Zillikens, A. Zandbergen, 2011 .

Adult-Onset Pompe Disease Presenting with Severe Fatigue and Selective Involvement of Type 1 Muscle Fibers

P. Doorn, A. Reuser, A. Ploeg, 2011 .

A case of adult Pompe disease presenting with severe fatigue and selective involvement of type 1 muscle fibers

R. Verdijk, P. Doorn, A. Reuser, 2011, Neuromuscular Disorders.

Muscle fiber-type distribution, fiber-type-specific damage, and the Pompe disease phenotype

M. Drost, J. D. Laat, P. Doorn, 2013, Journal of Inherited Metabolic Disease.

G.O.19 Results of a phase II study to assess safety and efficacy of olesoxime (TRO19622) in 3–25 years old spinal muscular atrophy patients

E. Mercuri, F. Muntoni, F. Rivier, 2014, Neuromuscular Disorders.